NVO Latest Headlines

Kinnevik names Helena Saxon as new CEO

at seekingalpha.com (Mon, 25-May 4:23 AM)

SA Asks: What are the most attractive biotech stocks right now?

at seekingalpha.com (Sun, 24-May 4:13 PM)

Kepler Capital Keeps Their Hold Rating on Novo Nordisk (0QIU)

at www.tipranks.com (Sat, 23-May 9:35 PM)

Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU

at www.tipranks.com (Fri, 22-May 2:57 PM)

Novo gets EU backing for higher-dose Wegovy in single-dose pen

at seekingalpha.com (Fri, 22-May 2:10 PM)

Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial

at www.tipranks.com (Fri, 22-May 12:34 PM)

Novo Nordisk’s AMAZE 4 Trial Targets Obesity and Sleep Apnea for Next Growth Leg

at www.tipranks.com (Fri, 22-May 12:33 PM)

Novo Nordisk Wins EMA Panel Backing for First Oral Wegovy Obesity Pill in EU

at www.tipranks.com (Fri, 22-May 10:27 AM)

4 stocks to watch on Friday: AMD, MRK, NVO, SBUX

at seekingalpha.com (Fri, 22-May 8:44 AM)

Novo Nordisk wins EU endorsement for Wegovy pill

at seekingalpha.com (Fri, 22-May 8:41 AM)

Weight-loss drugs from Lilly, Novo linked to stalling cancer: report

at seekingalpha.com (Fri, 22-May 6:47 AM)

How does Lilly’s next-gen obesity drug compare to Novo’s

at seekingalpha.com (Thu, 21-May 12:27 PM)

Novo Nordisk Expands Its GLP-1 Leadership: New Phase 3 Data Points to Long-Term Growth Beyond Diabetes

Market Chameleon (Thu, 7-May 9:46 AM)

FDA Approves Novo Nordisk's Wegovy HD: New Injection Sets Highest Weight Loss Benchmark in STEP UP Trial

Market Chameleon (Fri, 20-Mar 11:00 AM)

FDA Approves Novo Nordisk’s Wegovy HD with Record Weight Loss Efficacy—STEP UP Trial Reveals 21% Average Reduction

Market Chameleon (Fri, 20-Mar 7:07 AM)